Full Year 2024 IXICO PLC Earnings Call Transcript

The following is excerpted from the question-and-answer section of the transcript.

Question: Paul Hill - Vox Markets - Analyst : Brilliant. Thanks, Bram and Grant. (event instructions) We got one beforehand from David. He was asking about the GBP2-million Huntington Disease contract. Bram, if you could just provide a bit of color on whether it's typical that size within the pipeline that you see, especially in Parkinson's and Alzheimer's.

Question: Paul Hill - Vox Markets - Analyst : Just what you're doing it in the actual contract, is it basically Phase 2, Phase 3 digital imaging?

Question: Paul Hill - Vox Markets - Analyst : Okay, good. We've got one from John's fairly related. He's asking about who's IXICO's main competitors are and what the company's like core differentiators are?

Question: Paul Hill - Vox Markets - Analyst : Okay. And the second part of John's was just asking about whether it was possible for the likes of Google or Apple to do this because obviously they put -- they moved into radiology x-ray analysis.

Question: Paul Hill - Vox Markets - Analyst : Okay. Got one from Rebecca asking about new services. How long is it likely to take to move into or to get the biomarkers developed for Parkinson's and Alzheimer's? And also, the timeline and what you need to do is to move into the marketing surveillance sector.

Question: Paul Hill - Vox Markets - Analyst : Okay, good. I've got one from [Ben] just on the financials here, Grant. He's asking about current trading since September and visibility going forward for the rest of the year. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. DECEMBER 04, 2024 / 4:30PM, IXI.L - Full Year 2024 IXICO PLC Earnings Call

Question: Paul Hill - Vox Markets - Analyst : Okay, good. We've got a follow-up from Robert. He's asking about when IXICO is likely to become profitable, which is obviously important for everybody?

Question: Paul Hill - Vox Markets - Analyst : Okay, good. We've got another one from George on the cash side. Obviously, you've just raised. He's asking about whether you'll need to -- whether that's going to be sufficient for the business going forward to reach cash flow self-payment, yeah.

Question: Paul Hill - Vox Markets - Analyst : Okay, good. We've got one coming in from Alan. He's asking about strategic partnerships and how you see that developing, Bram.

Question: Paul Hill - Vox Markets - Analyst : Okay, good. (event instructions) We got one from Tom asking about your pipeline. Bram, how the pipeline is developing and where you like the business to get to in three to five years?

Question: Paul Hill - Vox Markets - Analyst : Great. Okay. REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. DECEMBER 04, 2024 / 4:30PM, IXI.L - Full Year 2024 IXICO PLC Earnings Call Well, just a reminder if anybody wants to -- that's the final questions. Otherwise, I am going to close it. I think they're probably there but I'd like to say a big thanks to everyone for your questions and likewise to Grant and to Bram for taking us through all the presentation. I found it fascinating, so thanks very much guys and big congrats and we all hope given the importance of the area you work and we all hope you make it a roaring success. So thanks, guys.